Compare Becton Dickinson and Co (BDX) vs Costco Wholesale Corporation (COST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs Costco Wholesale Corporation — how do they compare? Becton Dickinson and Co trades at $156.66 (market cap $41.51B), while Costco Wholesale Corporation trades at $924.42 (market cap $408.78B). The key difference: Costco Wholesale Corporation is far larger — about 9.8× Becton Dickinson and Co's market cap, and Becton Dickinson and Co pays the higher dividend (2.79%). Which is the better fit depends on your goals.
| BDX | COST | |
|---|---|---|
Market Cap | $41.51B | $408.78B |
Sector | Health | Consumer Staples |
52-Week High | $185.39 | $1.09K |
52-Week Low | $135.49 | $849.63 |
Enterprise Value | $57.97B | $396.92B |
Dividend Yield | 2.79% | 0.64% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BDX trades at $153.83, up 1.24% today, with technical indicators showing a neutral to bullish bias. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $2.90 exceeding expectations. Revenue growth remains steady, reaching $21.84B in 2025, though net margins have compressed to 5.12%. Recent news highlights BDX's innovation in medical technology and positive analyst sentiment.
The outlook for BDX appears balanced. Upside potential exists from continued earnings beats and strategic positioning in growing healthcare segments like GLP-1 drug support equipment. However, risks include margin pressure, elevated debt levels, and cautious hospital spending. The consensus price target of $173.40 suggests moderate upside from current levels.
Costco Wholesale Corporation (COST) trades at $923.76, down 0.29% on the day, as technical indicators signal a bearish trend with the price near pivot point support. Fundamentally, the company shows consistent revenue growth, reaching $275.24B in 2025, and strong cash flow generation of $13.34B from operations, though valuation metrics like a P/E of 46.37 appear elevated. Recent news highlights a March sales surge of 11.3% year-over-year and the first membership fee increase in seven years, which analysts view positively for future profit growth.
The investment outlook balances strong business fundamentals against a high valuation and near-term technical weakness. Upside potential is supported by robust membership renewal rates, expanding margins, and a consensus price target of $1,120. Key risks include sensitivity to consumer spending, competitive pressures in retail, and the stock's premium valuation requiring sustained execution to justify further gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About Costco Wholesale Corporation
The leading warehouse club, Costco has 815 stores worldwide (at the end of fiscal 2021), with most sales derived in the United States (72%) and Canada (14%). It sells memberships that allow customers to shop in its warehouses, which feature low prices on a limited product assortment. Costco mainly caters to individual shoppers, but roughly 20% of paid members carry business memberships. Food and sundries accounted for 40% of fiscal 2021 sales, with non-food merchandise 29%, warehouse ancillary and other businesses (such as fuel and pharmacy) nearly 17%, and fresh food 14%. Costco's warehouses average around 146,000 square feet
Read more on COST →
